Key facts
- Emium’s last known valuation is $10.9M (Mar 2025).
- It has raised $7.5M; the latest was Later Stage VC ($5.6M) in Mar 2025.
- Notable investors include Mitsubishi UFJ Capital, DNX Ventures, Aozora Corporate Investment, Beyond Next Ventures, 1stRound.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Emium
- ·The full record, as it builds
Funding rounds
No funding rounds for Emium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Emium
Operator of a digital healthcare platform designed to facilitate remote medical consultations and pharmaceutical distribution through a unified mobile interface. The company's platform offers integrated video conferencing for virtual doctor visits, electronic prescription management, automated medication delivery tracking, and secure health data storage, with symptom-monitoring tools, enabling patients and medical practitioners to maintain continuity of care while significantly reducing the physical travel requirements and administrative burdens associated with traditional clinical appointments.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2020
- Employees
- 4
- Website
- corp.emium.co.jp/
- Ownership
- Privately Held (backing)
Emium doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Emium shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Emium in its N-PORT filings yet. We sweep new filings monthly.